Filter
726
Text search:
Pharmaceutical
procurement
and
distribution
Featured
Recommendations
68
New Publications
236
Language
Document type
No document type
379
Studies & Reports
149
Guidelines
97
Strategic & Response Plan
49
Manuals
35
Fact sheets
7
Situation Updates
6
Training Material
3
Resource Platforms
1
Countries / Regions
Ethiopia
43
Kenya
40
Uganda
27
Nigeria
23
India
23
Sierra Leone
22
Global
21
South Africa
20
Liberia
19
Ghana
17
Malawi
15
Tanzania
14
Namibia
14
Nepal
13
Rwanda
12
Zambia
11
Ukraine
11
Zimbabwe
10
Lesotho
10
Western and Central Europe
10
Philippines
8
Bangladesh
8
Cambodia
7
Eastern Europe
7
Indonesia
6
Myanmar / Burma
6
Latin America and the Carribbean
6
Africa
6
Burkina Faso
5
Senegal
5
Congo, Democratic Republic of
5
Syria
5
Benin
5
Botswana
5
Asia
5
Cameroon
3
Haiti
3
Mozambique
3
Papua New Guinea
3
Sudan
3
West and Central Africa
3
South–East Asia Region
3
Thailand
2
Eswatini/ Swaziland
2
East and Southern Africa
2
Western Pacific Region
2
Albania
2
North America
2
Guinea
1
Mali
1
Somalia
1
South Sudan
1
Jordan
1
Central African Republic
1
Brazil
1
Libya
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Southern Africa
1
Laos
1
Timor Leste/ East Timor
1
Tajikistan
1
Moldova
1
Vietnam
1
Gabon
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
393
Clinical Guidelines
38
Key Resources
30
Public Health
21
Pharmacy & Technologies
19
Women & Child Health
12
Capacity Building
2
Annual Report MEDBOX
1
Toolboxes
Pharmacy
77
AMR
67
COVID-19
47
HIV
40
TB
34
NTDs
17
Conflict
13
Rapid Response
12
Health Financing Toolbox
12
Malaria
11
Planetary Health
10
NCDs
9
Ebola & Marburg
8
Global Health Education
8
Mental Health
5
2.0 Rapid Response
4
Natural Hazards
3
Disability
2
Cholera
2
Polio
2
Refugee
2
Caregiver
2
Zika
1
Specific Hazards
1
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID
...
This is an update of a seven-year TB and Leprosy national strategic plan (TBL-NSP), which extends from 2013 to 2020. The update focuses on the plan covering from 2017-20 and is based on the 2017 ext
...
WHO guideline on balanced national controlled medicines policies to ensure medical access and safety
Access to medicines is essential for attainment of universal health coverage, which is central to achievement of the health-related Sustainable Development Goals. Controlled medicines include those such as opioids, benzodiazepines, barbiturates, amphetamines
...
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa
...
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Actio
...
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and ex
...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicabl
...
Improvements in water sanitation and hygiene (WASH) and wastewater management in all sectors are critical elements of preventing infections and red
...
